Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F0XR7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,497
Award facts
- Contract value 100% obligated
- $39,496.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $39,496.91 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a firm fixed price and delivery to the company's headquarters in Conshohocken, Pennsylvania. The award, issued on December 4, 2025, with completion scheduled for December 5, 2025, was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Repatha (evolocumab) is a PCSK9 inhibitor used for managing high cholesterol and cardiovascular disease, representing a specialized pharmaceutical product within the Defense Health Agency's medical supply chain. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor supporting military and veteran healthcare systems, with delivery orders consistently featuring brand-name medications, specialty drugs, and medical devices across multiple therapeutic domains. The company's substantial IDC with DLA positions it as a primary vendor for federal pharmaceutical procurement needs serving defense and related federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0XR7?
SPE2DR26F0XR7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F0XR7 worth?
The government has obligated $39,497 on SPE2DR26F0XR7.
Is contract SPE2DR26F0XR7 an order under another contract?
Yes. SPE2DR26F0XR7 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0XR7 competed?
The extent of competition for SPE2DR26F0XR7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award